Newsoara Biopharma 
Welcome,         Profile    Billing    Logout  
  Products    Diseases    Products    Trials    News 

Download options
                                                                                                      
 Phase 
N/A
1
2
3
4
 Trials
 036912151821242730
            
            
             
ZEN-3694 / Zenith Epigenetics           
          
            
             
olvimulogene nanivacirepvec (GL-ONC1) / Genelux           
          
            
             
prifemilast (HPP737) / Newsoara Biopharma, cAMPfield Therapeutics           
          
            
             
tinodasertib (AUM001) / AUM Biosci